Acarbose
Alpha Glucosidase Inhibitors
- Drug class
- Alpha Glucosidase Inhibitors
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 3
- Products on record
- 10
- FDA reports (12 mo)
- 218
Overview
Acarbose is an active pharmaceutical ingredient in the Alpha Glucosidase Inhibitors group (A10BF). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 7 | April 10, 2026 |
| CA Canada | Health Canada | 2 | March 22, 2025 |
| US United States | FDA | 1 | August 12, 2024 |
GBUnited Kingdom· MHRA
7 products
Uses
Acarbose is indicated in adults and adolescents aged over 18 years. Acarbose is recommended for the treatment of type II diabetes mellitus in patients inadequately controlled on diet alone, or on diet and oral hypoglycaemic agents.
How to take
CACanada· Health Canada
2 products
Uses
AND CLINICAL USE .................................................................................. 3 CONTRAINDICATIONS .................................................................................................... 4 WARNINGS AND PRECAUTIONS ....................................................................................
4 ADVERSE REACTIONS.................................................................................................... 6 DRUG INTERACTIONS ....................................................................................................
8 DOSAGE AND ADMINISTRATION ................................................................................... 9 OVERDOSAGE ...............................................................................................................
10 ACTION AND CLINICAL PHARMACOLOGY .................................................................. 10 STORAGE AND STABILITY ............................................................................................ 12 DOSAGE FORMS, COMPOSITION AND PACKAGING ..................................................
USUnited States· FDA
1 product
Uses
INDICATIONS AND USAGE
Acarbose tablets, USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
How to take
Drug interactions
Known interactions involving Acarbose. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 336. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL045691620 · revised April 10, 2026
- [2]Health Canada (DPD) · 02494078 · revised March 22, 2025
- [3]FDA DailyMed · 067c0adc-7322-48… · revised August 12, 2024 [PDF]
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.